See how Langraph powers a multi-agent stock sim with configurable rounds and models, helping you compare trade plans without ...

Anthropic's Ralph plugin keeps Claude retrying until specs pass, with a stop hook to pause loops, so you ship cleaner code ...

The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Poppy and Nick O'Hagan discuss the benefits of theatrical windows and community in the age of Netflix and A24, launching with director Richard Hawkins' Tallinn-premiering title, and their next ...

Bowing in Tallinn’s official competition, “Think of England” is the long-awaited sophomore pic of BAFTA-nominated British writer-director Richard Hawkins. If his directorial debut “Everything” (2004) ...

The percentage of Americans who believe the Democratic Party is “out of touch” has increased by double-digits over the last decade, with 70% indicating the party is disconnected from the issues that ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...